The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study

INTRODUCTION: Disease-modifying therapies (DMTs) in multiple sclerosis (MS) are chronic therapies, and patients are likely to face challenges in adhering to DMT dosing regimens over time. DMT manufacturers offer patient support programs (PSPs) to increase adherence. PSPs are managed offerings typica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenz, Florian, Harms, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467433/
https://www.ncbi.nlm.nih.gov/pubmed/32333326
http://dx.doi.org/10.1007/s12325-020-01349-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467433/
https://www.ncbi.nlm.nih.gov/pubmed/32333326
http://dx.doi.org/10.1007/s12325-020-01349-3

Ejemplares similares